Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer
Clinical trial NCT04557306 · COMPLETED
Trial details
- NCT number
- NCT04557306
- Sponsor
- CHABiotech CO., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2021-10-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.